Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Diabetic Kidney Disease, Type 2 Diabetes”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01712061
What this trial is testing

Multi-Center Study To Evaluate The Efficacy And Safety Of A Chemokine CCR2/5 Receptor Antagonist In Adults With Type 2 Diabetes And Overt Nephropathy

Who this might be right for
Diabetic Nephropathy
Pfizer 226
Large-scale testing (Phase 3)WithdrawnNCT03105219
What this trial is testing

IvaBradinE to Treat MicroalbumiNuria in Patients With Type 2 Diabetes and Coronary Heart Disease

Who this might be right for
Diabetic Kidney Disease
Nanjing First Hospital, Nanjing Medical University
Large-scale testing (Phase 3)Study completedNCT00004266
What this trial is testing

Drugs for High Blood Pressure and High Cholesterol in American Indians With Type 2 Diabetes

Who this might be right for
Diabetic Nephropathy
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 160
Large-scale testing (Phase 3)Ended earlyNCT02410005
What this trial is testing

Intervention Using Vitamin D for Elevated Urinary Albumin Treated With Losartan in Diabetes (IDEAL)

Who this might be right for
Diabetic Nephropathies
Weill Cornell Medical College in Qatar 56
Post-approval studies (Phase 4)Study completedNCT02914691
What this trial is testing

Effects of Dapagliflozin Treatment on Urinary Proteomic Patterns in Patients With Type 2 Diabetes

Who this might be right for
Type 2 DiabetesDiabetic Nephropathy
Peter Rossing 40
Not applicableStudy completedNCT06833541
What this trial is testing

Research on Gut Microbiota and Metabolomics in Diabetic Kidney Disease

Who this might be right for
Diabetic Nephropathy Type 2Type 2 Diabetes Mellitus (T2DM)Chronic Kidney Disease
The First Affiliated Hospital of Hunan University of Traditional Chinese Medicine 556
Testing effectiveness (Phase 2)Study completedNCT01109212
What this trial is testing

The Effects of Bindarit in Diabetic Nephropathy

Who this might be right for
Diabetic Nephropathy
Aziende Chimiche Riunite Angelini Francesco S.p.A 100
Post-approval studies (Phase 4)Study completedNCT00234871
What this trial is testing

Tarka® vs. Lotrel® in Hypertensive, Diabetic Subjects With Renal Disease (TANDEM)

Who this might be right for
HypertensionDiabetesProteinuria
Abbott 357
Not applicableStudy completedNCT04931030
What this trial is testing

Low Carbohydrate Diet in Diabetic Kidney Disease

Who this might be right for
Type 2 Diabetes MellitusDiabetic Kidney DiseaseObesity
Universiti Teknologi Mara 30
Not applicableStudy completedNCT02001532
What this trial is testing

Arterial Stiffness and Complication Risk in Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2Diabetes ComplicationsDiabetic Angiopathies+1 more
Aarhus University Hospital 140
Post-approval studies (Phase 4)Study completedNCT03047278
What this trial is testing

Transporters for Organic Cations and Glycemic Control in Patients With Neuropathic Pain.

Who this might be right for
Neuropathic PainType 2 Diabetes MellitusDiabetic Neuropathy, Painful
Natalia Valadares de Moraes 29
Testing effectiveness (Phase 2)Study completedNCT03627715
What this trial is testing

Safety and Effectiveness of Propagermanium in Diabetic Kidney Disease Participants Receiving Irbesartan

Who this might be right for
Diabetic Kidney Disease
Dimerix Bioscience Pty Ltd 45
Post-approval studies (Phase 4)Study completedNCT00363987
What this trial is testing

Controlled Study to Evaluate Efficacy and Safety of α-KA Tab With Low Protein Diet (LPD) in Delaying the Progress of Type 2 Diabetic Nephropathy (DN)

Who this might be right for
Diabetic Nephropathy
Fresenius Kabi 179
Testing effectiveness (Phase 2)Study completedNCT02316821
What this trial is testing

The Phase II Study of Bardoxolone Methyl in Patients With Chronic Kidney Disease and Type 2 Diabetes; TSUBAKI Study

Who this might be right for
Chronic Kidney DiseaseType 2 Diabetes
Kyowa Kirin Co., Ltd. 216
Post-approval studies (Phase 4)Study completedNCT00419835
What this trial is testing

Effect of Enalapril and Losartan Association Therapy on Proteinuria and Inflammatory Biomarkers in Diabetic Nephropathy: a Clinical Trial on Type 2 Diabetes Mellitus

Who this might be right for
Macroalbuminuric Diabetic Nephropathy
University of Sao Paulo 80
Not applicableLooking for participantsNCT04916132
What this trial is testing

Diabetic Nephropathy in People With Diabetes. Prevalence and Predictive Factors

Who this might be right for
Chronic Kidney DiseasesAlbuminuriaDiabetic Kidney Disease+4 more
Herlev Hospital 300
Not applicableActive Not RecruitingNCT00342927
What this trial is testing

Family Investigation of Nephropathy and Diabetes (F.I.N.D.)

Who this might be right for
Diabetic NephropathyDiabetes MellitusDiabetic Kidney Disease+1 more
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 9,084
Testing effectiveness (Phase 2)WithdrawnNCT00755404
What this trial is testing

Effect of an L-Carnitine-Containing Peritoneal Dialysis (PD) Solution on Insulin Sensitivity in Diabetic Patients on Continuous Ambulatory Peritoneal Dialysis (CAPD)

Who this might be right for
End Stage Renal DiseaseDiabetes
Iperboreal Pharma Srl
Early research (Phase 1)Looking for participantsNCT07024823
What this trial is testing

Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4248 in Healthy Participants and Participants With Chronic Kidney Disease and Type 2 Diabetes and to Assess Home Measurements of Creatinine in a Non Interventional Cohort

Who this might be right for
Chronic Kidney Disease
AstraZeneca 124
Large-scale testing (Phase 3)Study completedNCT00800683
What this trial is testing

Safety and Efficacy in Type 2 Diabetic Patients With Severe Chronic Renal Impairment, 5 mg BI 1356 (Linagliptin) vs. Placebo, Insulin Background Inclusive

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 133
Next Page